Cheaper CAR-T therapy drawing global cancer patients to China
At 25, Michael Walters had already endured unsuccessful lymphoma treatments in New Zealand. A Melbourne hospital quoted up to US$600,000 for CAR-T therapy. He paid less than half t...
Search fresh public links, source activity, and ready-to-use post angles for China Cancer Treatment.
Fresh curated links around China Cancer Treatment are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
At 25, Michael Walters had already endured unsuccessful lymphoma treatments in New Zealand. A Melbourne hospital quoted up to US$600,000 for CAR-T therapy. He paid less than half t...
CancerFax Builds Trusted India-China Pathway for Advanced Cancer Treatment Access
A group of Hong Kong-listed biotechnology companies have seen their stock prices surge in the wake of Moderna’s breakthrough cancer vaccine trial, as the Chinese companies push for...
Chinese biopharmaceutical firm Akeso announced on Wednesday that its immunotherapy drug had outperformed AstraZeneca’s Imfinzi in a head-to-head phase-three trial for biliary tract...
Cancer is one of the most challenging health conditions, and choosing the right hospital can make an important difference in the treatment journey. A good cancer hospital should of...
Two US-developed treatments for breast cancer and a degenerative eye disease will undergo large-scale clinical trials in the Greater Bay Area in a collaboration involving Hong Kong...
The results were seen by Wall Street analysts as “direct proof-of-concept” that sac-TMT, a drug Merck views as a “cornerstone,” could be part of a future treatment standard for fro...
With multidisciplinary expertise, advanced surgical treatment, and continued support, KD Cancer Centre is building a comprehensive approach to cancer care, addressing both clinical...
There have been several promising developments lately in cancer research and treatment, including a new drug approved by the FDA this week for advanced pancreatic cancer. William B...
Kalinda Ukanwa Zeiger knew all the grim statistics associated with pancreatic cancer, the nation’s third deadliest cancer. Still, she had pivotal moments during her treatment where...
Advanced gastric and gastroesophageal junction cancers are receiving renewed attention after researchers reported a clinical study testing a three-part first-line treatment strateg...
With its latest foray into China, GSK acquired rights from Hutchmed to an “antibody-targeted therapy conjugate” impacting two well-known cancer drivers, EGFR and KRAS.
Forty-five Kiwi patients have participated among 1000 worldwide, with possible benefits for those with other forms of cancer.
By: Liz Highleyman From: cancerhealth.com The Food and Drug Administration (FDA) recently approved several new therapies for breast cancer, including for patients with metastatic (...
Peer-reviewed case report documents 90% volume reduction together with extensive necrosis — achieved without surgery or full-dose chemotherapy after gemcitabine failed SAN DIEGO, S...
Cancer-associated cachexia, the wasting syndrome that erodes muscle, fat and physical resilience in many people with advanced cancer, has long resisted treatment. Now, researchers...
The Moderna Neoantigen selection. A tumor carries thousands of mutations. Only a handful produce peptides that get presented on MHC and recognized by T cells. Moderna’s pipeline ta...
The cost of cancer is a steep one. The impact of a cancer diagnosis goes beyond physical, mental, and emotional factors to include a hefty treatment price tag that few can afford....
The incidence of cancer is not rare anymore in India. In the past two decades, the number of cancer patients has increased quite significantly in India. Though the Union Government...
TUESDAY, Aug. 25, 2026 — A new approach to treating metastatic breast cancer may allow some patients to avoid chemotherapy, at least initially. In a small early-stage trial recentl...
As a head-to-head Phase III trial comparing sac-TMT plus pembrolizumab with the first-line standard of care (immunotherapy plus chemotherapy), OptiTROP-Lung06 demonstrated the supe...
An experimental drug called CS18 weakened several cancer survival mechanisms and helped overcome treatment resistance in laboratory and animal studies. Cancer treatments can work a...
The Israeli-developed treatment uses RNA molecules to silence mutated KRAS genes and will be tested alongside standard therapy in patients with locally advanced disease.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.